Strengthening Private Provider Engagement to Improve TB Outcomes in Indonesia: An Institutional Review

The Global TB Report 2018 estimated a total of 842,000 new and relapse TB cases per year in Indonesia, while only 53% of estimated cases in 2017 were reported to the National Tuberculosis Program (NTP). Indonesia's National Tuberculosis Prevalence Survey (NPS) in 2014 indicated that 74% of initial care-seeking for TB and nearly half of all TB treatment occurs in the private sector among general practitioners, clinics, and hospitals operating outside the public health care system. The rapid expansion of Indonesia's JKN (Jaminan Kesehatan Nasional) insurance coverage is impacting diagnostic pathways and client and provider behaviors. The NTP's district-based public-private mix (DPPM) is prioritizing TB connections at two levels: between GPs and Puskesmas; and between hospitals and Dinas Kesehatan (the District Health Office, or DHO). In response to this situation, the US Agency for International Development (USAID) commissioned this review to deepen understanding of the institutional relationships and incentives of private sector health facilities and organizations in TB care in Indonesia. The objective of this review was to more fully understand the behaviors and underlying motivations of private sector institutions in order to identify potential ways to improve the quality of TB services in the private sector. The review addressed five study objectives, including understanding the business case for providing TB services and drugs in private sector, understanding attitudes among private sector providers toward participation in JKN, and developing district-level estimates of unreported TB cases treated in private sector. The review found that the private sector plays a significant role in TB treatment in Indonesia, with 74% of initial care-seeking for TB and nearly half of all TB treatment occurring in the private sector. However, only 13% of TB cases reported to the NTP in 2017 originated from private providers. The review also found that the rapid expansion of JKN insurance coverage is impacting diagnostic pathways and client and provider behaviors. The review identified several key findings, including the need to improve the quality of TB services in the private sector, the importance of understanding the business case for providing TB services and drugs in private sector, and the need to develop district-level estimates of unreported TB cases treated in private sector. The review also identified several potential solutions, including using JKN as a lever to change the behaviors of private sector providers, and developing a landscape of key district-level actors. The review was conducted in six districts in Indonesia, including Tulungagung, North Jakarta, Medan, Kabupaten Tangerang, Kota Tangerang, and Makassar. The review involved a combination of qualitative and quantitative research methods, including interviews with private sector providers, analysis of data on TB cases, and review of existing literature on TB care in Indonesia. The review's findings and recommendations will be used to inform USAID's upcoming Tuberculosis Private Sector (TBPS) activity, which will serve as USAID's main investment in supporting Indonesia in improving TB services in the private sector. The review's findings and recommendations will also be used to support the implementation of future initiatives to increase uptake and improve the quality of TB services in the private sector.